Anthropic on Tuesday released Claude Sonnet 4.6, a model that amounts to a seismic repricing event for the AI industry. It delivers near-flagship intelligence at mid-tier cost, and it lands squarely ...
PRINCETON, NJ, Dec. 04, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the "Company" or "Sonnet”) (NASDAQ: SONN), a clinical-stage company developing innovative targeted ...
The maximum tolerated dose (MTD) of SON-1010 was set at 1200 ng/kg, without dose-limiting toxicity or evidence of cytokine release syndrome at any dose level Stable disease (SD) at four months ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results